| 71 |
Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome |
2019 |
| 72 |
Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome. |
2019 |
| 73 |
Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute |
2019 |
| 74 |
Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute |
2019 |
| 75 |
Prognostic significance of absolute lymphocytic count recovery in pediatric patients with acute lymphoblastic leukemia at south Egypt cancer institute |
2019 |
| 76 |
Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients |
2019 |
| 77 |
Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) |
2019 |
| 78 |
Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) |
2019 |
| 79 |
Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) |
2019 |
| 80 |
Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) |
2019 |
